Profil

Von Frenckell Christian

Département des sciences cliniques

See author's contact details
Main Referenced Co-authors
Malaise, Olivier  (19)
Malaise, Michel  (18)
Guiot, Julien  (6)
Ribbens, Clio  (5)
Andre, Béatrice  (4)
Main Referenced Keywords
Humans (3); Interstitial lung disease (3); Medicine (all) (2); Myositis (2); Tumor Necrosis Factor-alpha (2);
Main Referenced Unit & Research Centers
d‐BRU - Dental Biomaterials Research Unit - ULiège [BE] (1)
Main Referenced Disciplines
Rheumatology (21)
Immunology & infectious disease (4)
General & internal medicine (3)
Cardiovascular & respiratory systems (2)
Urology & nephrology (2)

Publications (total 29)

The most downloaded
1012 downloads
JADOT, V., Krzesinski, J.-M., VON FRENCKELL, C., BOVY, C., & BOUQUEGNEAU, A. (2017). La néphropathie lupique : les nouvelles perspectives de traitement. Néphrologie et Thérapeutique, 14, 1-12. doi:10.1016/j.nephro.2017.05.002 https://hdl.handle.net/2268/229715

The most cited

480 citations (Scopus®)

Niemi, M., Gazon, H., JUSZCZAK, D., FADEUR, M., CAMBY, S., MEURIS, C., THYS, M., JACQUES, J., HENKET, M., BEGUIN, Y., Rahmouni, S., Lebrun, M., MOUTSCHEN, M., Misset, B., DARCIS, G., GUIOT, J., AZARZAR, S., DELLOT, P., GOFFLOT, S., ... HUYNEN, P. (Other coll.). (2021). Mapping the human genetic architecture of COVID-19. Nature, 600, 472-477. doi:10.1038/s41586-021-03767-x https://hdl.handle.net/2268/260539

Bolland, M., Malaise, O., Seidel, L., Meunier, P., Ribbens, C., & Von Frenckell, C. (September 2023). Systematic screening of swallowing disorders in idiopathic inflammatory myopathies: a retrospective study [Paper presentation]. Belgian Congress of Rheumatology.
Peer reviewed

Lehane, F., Von Frenckell, C., Docampo Martínez, E., Ribbens, C., & Malaise, O. (March 2023). Fibromyalgia … 
But does your liver agree with this diagnosis? [Paper presentation]. Bone Curriculum Symposium 2023.
Peer reviewed

CHAUVEHEID, F., Von Frenckell, C., Colin, G., DEFLANDRE, E., Piette, Y., Duysinx, B., Bianchi, E., Malaise, M., & Malaise, O. (July 2022). Poussée sévère d’une dermatomyosite pré-existante chez une patiente avec un adénocarcinome pulmonaire traité par pembrolizumab, un anti-PD-1. Revue Médicale de Liège, 77 (7-8), 462-467.
Editorial Reviewed verified by ORBi

TYBERGHEIN, M., VON FRENCKELL, C., & WANG, F.-C. (May 2022). ENMG DES MYOPATHIES INFLAMMATOIRES [Poster presentation]. 22èmes Journées Francophones d'ElectroNeuroMyoGraphie, Marrakech, Morocco.
Peer reviewed

Nakanishi, T., Pigazzini, S., Degenhardt, F., Cordioli, M., Butler-Laporte, G., Maya-Miles, D., Nafría-Jiménez, B., Bouysran, Y., Niemi, M., Palom, A., Ellinghaus, D., Khan, A., Martínez-Bueno, M., Rolker, S., Amitano, S., Tato, L. R., Fava, F., Spinner, C. D., Prati, D., ... consortium, C.-H. (October 2021). Age-dependent impact of the major common genetic risk factor for COVID-19 on severity and mortality. Journal of Clinical Investigation, Online ahead of print.. doi:10.1172/JCI152386
Peer Reviewed verified by ORBi

Maloir, Q., SEIDEL, L., VON FRENCKELL, C., GESTER, F., LOUIS, R., & GUIOT, J. (2021). Clinical experience in anti-synthetase syndrome: a monocentric retrospective analytical study. Acta Clinica Belgica. doi:10.1080/17843286.2021.1925818
Peer Reviewed verified by ORBi

Gendebien, Z., VON FRENCKELL, C., RIBBENS, C., ANDRE, B., THYS, M., GANGOLF, M., SEIDEL, L., MALAISE, M., & MALAISE, O. (March 2021). Systematic analysis of Covid-19 infection and symptoms in a systemic lupus erythematous population: correlation with disease characteristics, hydroxychloroquine use and immunosuppressive treatments [Paper presentation]. Belgian congress of rheumatology 2021.
Peer reviewed

Niemi, M., Gazon, H., JUSZCZAK, D., FADEUR, M., CAMBY, S., MEURIS, C., THYS, M., JACQUES, J., HENKET, M., BEGUIN, Y., Rahmouni, S., Lebrun, M., MOUTSCHEN, M., Misset, B., DARCIS, G., GUIOT, J., AZARZAR, S., DELLOT, P., GOFFLOT, S., ... HUYNEN, P. (Other coll.). (2021). Mapping the human genetic architecture of COVID-19. Nature, 600, 472-477. doi:10.1038/s41586-021-03767-x
Peer Reviewed verified by ORBi

CHAUVEHEID, F., VON FRENCKELL, C., Colin, G., DEFLANDRE, E., DUYSINX, B., Piette, Y., Malaise, M., & MALAISE, O. (December 2020). Traiter un cancer pulmonaire avec une dermatomyosite « paranéoplasique » associée par un inhibiteur des points de contrôle immunitaire : une fausse bonne idée ? Revue du Rhumatisme, 87 (S1), 235-A236. doi:10.1016/j.rhum.2020.10.420
Peer reviewed

CHAUVEHEID, F., VON FRENCKELL, C., Colin, G., DEFLANDRE, E., Piette Yves, DUYSINX, B., MALAISE, M., & MALAISE, O. (September 2020). Treating cancer with associated paraneoplastic dermatomyositis with immune checkpoint inhibitor, a false good idea? [Paper presentation]. Belgian congress of rheumatology.
Peer reviewed

MALAISE, M., CHAPELIER, N., DEWAEL, T., LEONORI, L., LEROY, M., Mailleux, E., André, B., Halleux, S., KAISER, M.-J., MALAISE, O., RIBBENS, C., RINKIN, C., VON FRENCKELL, C., & VOLDERS, A. (May 2020). Une révolution thérapeutique en rhumatologie : oui, mais… Revue Médicale de Liège, 75 (5-6), 369-375.
Editorial Reviewed verified by ORBi

Gendebien, Z., VON FRENCKELL, C., RIBBENS, C., ANDRE, B., THYS, M., GANGOLF, M., SEIDEL, L., Malaise, M., & MALAISE, O. (2020). Systematic analysis of COVID-19 infection and symptoms in a systemic lupus erythematosus population: correlation with disease characteristics, hydroxychloroquine use and immunosuppressive treatments. Annals of the Rheumatic Diseases. doi:10.1136/annrheumdis-2020-218244
Peer Reviewed verified by ORBi

GESTER, F., DUYSINX, B., VON FRENCKELL, C., Louis, R., & GUIOT, J. (2019). Comment j'explore... Les modifications biologiques dans les pathologies infiltrantes pulmonaires. Revue Médicale de Liège, 74 (1), 47-53.
Peer reviewed

Maloir, Q., Ghysen, K., VON FRENCKELL, C., Louis, R., & GUIOT, J. (2018). Détresse respiratoire aiguë révélatrice d'un syndrome des antisynthétases. Revue Médicale de Liège, 73 (7-8), 370-375.
Peer reviewed

DELVENNE, E., Farnir, F., GUIOT, J., GIOT, J.-B., & VON FRENCKELL, C. (2017). Abcès cérébraux à nocardia farcinica dans le cadre d'une infection systémique. Revue Médicale de Liège, 72 (7-8), 340-343.
Peer reviewed

JADOT, V., Krzesinski, J.-M., VON FRENCKELL, C., BOVY, C., & BOUQUEGNEAU, A. (2017). La néphropathie lupique : les nouvelles perspectives de traitement. Néphrologie et Thérapeutique, 14, 1-12. doi:10.1016/j.nephro.2017.05.002
Peer Reviewed verified by ORBi

MALAISE, O., CHAUVEHEID, F., VON FRENCKELL, C., LEONARD, P., MOUTSCHEN, M., DEMONTY, J., & MALAISE, M. (September 2015). Newly diagnosed adult onset Still’s disease between 2002 and 2014: retrospective clinical biological and therapeutic characterization. Comparison with 1988 – 2001 data [Poster presentation]. Belgian congress of Rheumatology 2015.
Peer reviewed

MALAISE, O., GESTER, F., Thonnard Anne-Sophie, Marchetta Stella, VON FRENCKELL, C., & MALAISE, M. (September 2015). Pericarditis revealing an anti-Jo-1 anti-synthetase syndrome in an elderly patient [Poster presentation]. Belgian congress of rheumatology 2015.
Peer reviewed

VON FRENCKELL, C., & DELANAYE, P. (2015). Rituximab (MabThera®) : nouveau médicament dans les vascularites associées à ANCA. Revue Médicale de Liège, 70 (2), 92-100.

MALAISE, O., JACQUERIE, P., Halleux, S., LUTTERI, L., VON FRENCKELL, C., & Malaise, M. (December 2014). Co-existence des anticorps anti-ADN double brin et des anticorps anti-peptides citrullinés: entre lupus médicamenteux induit et rhupus [Poster presentation]. Congrès de la Société Française de Rhumatologie 2014.
Peer reviewed

MALAISE, O., LIBON, F., BRICMAAN J, VON FRENCKELL, C., SIMONI, P., LEONARD P, & Malaise, M. (22 January 2014). Two spondylodiscitis due to a contamination by Brucella melitensis in a mother and daughter back from holidays. Revue Médicale de la Suisse Romande, 10 (404), 197-200.
Peer Reviewed verified by ORBi

MALAISE, O., VON FRENCKELL, C., ANDRE, B., & Malaise, M. (28 August 2013). The management of systemic lupus erythematosus with biological therapies. Revue Médicale Suisse, 9 (395), 1507-11.
Peer Reviewed verified by ORBi

MALAISE, O., VON FRENCKELL, C., ANDRE, B., & MALAISE, M. (August 2013). The management of systemic lupus erythematosus with biological therapies. Revue Médicale de Liège, 28 (9(395)), 1507-11.
Peer reviewed

MALAISE, O., HALLEUX, S., VON FRENCKELL, C., LUTTERI, L., CHAPELLE, J.-P., & Malaise, M. (September 2012). Rhupus: when rheumatoid arthritis meets lupus. Revue Médicale de Liège, 67 (9), 475-84.
Peer reviewed

MALAISE, O., VON FRENCKELL, C., & Malaise, M. (May 2012). Genetic and environmental interactions on the development of rheumatoid arthritis. Revue Médicale de Liège, 67 (5-6), 305-13.
Peer reviewed

VON FRENCKELL, C., & Malaise, M. (2012). Targeted therapy in inflammatory disease: cytokines. Revue Médicale de Liège, 67 (22-8).

MALAISE, O., VON FRENCKELL, C., & MALAISE, M. (2012). Interactions de la génétique et de l’environnement sur le développement de la polyarthrite rhumatoïde. Revue Médicale de Liège, 67 (5-6), 305-313.
Peer reviewed

Von Frenckell, C., & Malaise, M. (2009). Les traitements biologiques en rhumatologie. Revue Médicale de Liège, 64 (5-6), 293-300.
Peer reviewed

Von Frenckell, C., Henno, A., de LA BRASSINNE, M., & Malaise, M. (2007). Le traitement biologique des maladies inflammatoires à médiation immune. Le cas de la dermatologie et de la rhumatologie. Revue Médicale de Liège, 62 (Spec No), 55-62.
Peer reviewed

Contact ORBi